Acute Myeloid Leukaemia: New Targets and Therapies

被引：2
作者：
Brown, Geoffrey [1 ,2 ]
Marcinkowska, Ewa [3 ]
机构：
[1] Univ Birmingham, Inst Clin Sci, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Inst Immunol & Immunotherapy, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England
[3] Univ Wroclaw, Lab Prot Biochem, Fac Biotechnol, Joliot Curie 14a, PL-50383 Wroclaw, Poland
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2017年 / 18卷 / 12期
关键词：
MYELODYSPLASTIC SYNDROME; CLINICAL-OUTCOMES; EXPRESSION; GENE; FLT3; CLASSIFICATION; TRANSLOCATION; MUTATIONS; CELLS; LINE;
D O I：
10.3390/ijms18122577
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：4
相关论文
共 28 条
  • [1] Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study
    Almeida, Antonio M.
    Prebet, Thomas
    Itzykson, Raphael
    Ramos, Fernando
    Al-Ali, Haifa
    Shammo, Jamile
    Pinto, Ricardo
    Maurillo, Luca
    Wetzel, Jaime
    Musto, Pellegrino
    Van De Loosdrecht, Arjan A.
    Costa, Maria Joao
    Esteves, Susana
    Burgstaller, Sonja
    Stauder, Reinhard
    Autzinger, Eva M.
    Lang, Alois
    Krippl, Peter
    Geissler, Dietmar
    Francisco Falantes, Jose
    Pedro, Carmen
    Bargay, Joan
    Deben, Guillermo
    Garrido, Ana
    Bonanad, Santiago
    Diez-Campelo, Maria
    Thepot, Sylvain
    Ades, Lionel
    Sperr, Wolfgang R.
    Valent, Peter
    Fenaux, Pierre
    Sekeres, Mikkael A.
    Greil, Richard
    Pleyer, Lisa
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (04)
  • [2] Almeida Antonio M, 2016, Leuk Res Rep, V6, P1, DOI 10.1016/j.lrr.2016.06.001
  • [3] PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS
    BENNETT, JM
    CATOVSKY, D
    DANIEL, MT
    FLANDRIN, G
    GALTON, DAG
    GRALNICK, HR
    SULTAN, C
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) : 451 - &
  • [4] Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL):: a retrospective study from the European APL Group
    Callens, C
    Chevret, S
    Cayuela, JM
    Cassinat, B
    Raffoux, E
    de Botton, S
    Thomas, X
    Guerci, A
    Fegueux, N
    Pigneux, A
    Stoppa, AM
    Lamy, T
    Rigal-Huguet, F
    Vekhoff, A
    Meyer-Monard, S
    Ferrand, A
    Sanz, M
    Chomienne, C
    Fenaux, P
    Dombret, H
    [J]. LEUKEMIA, 2005, 19 (07) : 1153 - 1160
  • [5] T315 Decreases Acute Myeloid Leukemia Cell Viability through a Combination of Apoptosis Induction and Autophagic Cell Death
    Chiu, Chang-Fang
    Weng, Jing-Ru
    Jadhav, Appaso
    Wu, Chia-Yung
    Sargeant, Aaron M.
    Bai, Li-Yuan
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (08)
  • [6] Conway O'Brien E., 2014, ADV HEMATOL, V2014, DOI DOI 10.1155/2014/103175
  • [7] Acute Myeloid Leukemia
    Doehner, Hartmut
    Weisdorf, Daniel J.
    Bloomfield, Clara D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (12) : 1136 - 1152
  • [8] Acute myeloid leukaemia in adults
    Ferrara, Felicetto
    Schiffer, Charles A.
    [J]. LANCET, 2013, 381 (9865) : 484 - 495
  • [9] Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment
    Gbolahan, Olumide Babajide
    Zeidan, Amer M.
    Stahl, Maximilian
    Abu Zaid, Mohammad
    Farag, Sherif
    Paczesny, Sophie
    Konig, Heiko
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (08)
  • [10] Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: A phase III trial (E2995)
    Greenberg, PL
    Lee, SJ
    Advani, R
    Tallman, MS
    Sikic, BI
    Letendre, L
    Dugan, K
    Lum, B
    Chin, DL
    Dewald, G
    Paietta, E
    Bennett, JM
    Rowe, JM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) : 1078 - 1086
123